20 Pazopanib in patients (pts) with advanced germ cell tumors (GCT): Results from an open-label, single-group, phase 2 trial (Pazotest-01)

A Necchi, D Raggi + Show 7 more

https://doi.org/10.1016/s1569-9056(16)60022-2

Copy DOI

Publication Date: Mar 1, 2016

Abstract

20 Pazopanib in patients (pts) with advanced germ cell tumors (GCT): Results from an open-label, single-group, phase 2 trial (Pazotest-01)

Full Text

Paper version not known

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Paper Title

Journal

Date

Author